Researchers
Simić, Dragan
Results 41-60 of 158
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2020 | Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry![]() | Lainscak, Mitja; Milinković, Ivan M. | Article | 21a+M21a+ |
| 2020 | Metabolic syndrome and mortality prediction in the seven countries' study: single or multifactorial![]() | Parapid, Biljana J. | Conference Paper | Mp. category will be shown later |
| 2019 | Sindrom izgaranja anesteziologa u univerzitetskim klinikama![]() | Milenović, Miodrag | Conference Paper | Mp. category will be shown later |
| 2019 | Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery![]() | Goodman, Shaun G; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Ašanin, Milika R.
| Article | 21a+M21a+ |
| 2019 | Glutathione Transferase P1 Polymorphism Might Be a Risk Determinant in Heart Failure![]() | Simeunović, Dejan | Article | 21M21 |
| 2019 | Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes![]() | Roe, Matthew T.; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Davidović, Goran T.
| Article | 21a+M21a+ |
| 2019 | Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial![]() | Jukema, J Wouter; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Davidović, Goran T.
| Article | 21a+M21a+ |
| 2019 | Glutathione transferase P1 and O2 polymorphisms might be risk determinants in heart failure caused by coronary artery disease![]() | Ćorić, Vesna | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2019 | Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial![]() | Szarek, Michael; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Davidović, Goran T.
| Article | 21M21 |
| 2019 | Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial![]() | Szarek, Michael; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Davidović, Goran T.
| Article | 21a+M21a+ |
| 2019 | Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial![]() | Steg, Philippe Gabriel; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Davidović, Goran T.
| Article | 21a+M21a+ |
| 2019 | Prothrombotic state as a causative of impaired left ventricular diastolic function in patients with primary antiphospholipid syndrome![]() | Đoković, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2019 | Impact of glutathione S-transferase M1, T1 and P1 gene polymorphisms on the chronic heart failure![]() | Janković, Nataša D.; Ćorić, Vesna M. | Conference Paper | Mp. category will be shown later |
| 2019 | Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial![]() | White, Harvey D; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Ašanin, Milika R.
| Article | 21a+M21a+ |
| 2018 | Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome![]() | Schwartz, GG; ...; Dilić, Mirza; ...; Ristić, Arsen D.
Ašanin, Milika R.
| Article | 21a+M21a+ |
| 2018 | Association of GSTM1, GSTP1 and GSTT1 polymorphisms with risk of chronic heart failure![]() | Janković, Nataša | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2017 | Impact of glutathione S-transferase M1 gene polymorphisms on the chronic heart failure![]() | Janković, Nataša N.; Simić, Dragan V. | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2017 | Myocardial bridges, neither rare nor isolated-Autopsy study![]() | Teofilovski-Parapid, Gordana | Article | 21M21 |
| 2017 | Novel Biomarkers of Heart Failure![]() | Savić-Radojević, Ana R. | Book parts | Mp. category will be shown later |
| 2017 | Sifilisni aortitis - prikaz slučaja![]() | Nedeljković-Arsenović, Olga M. | Conference Paper | Mp. category will be shown later |

